Beruflich Dokumente
Kultur Dokumente
Todays issue of PD
Pharmacy Daily today has
CW to honour penalty rates emla recommended
Aspen Pharmacares emla dermal
Chemist Warehouse and My and Public Holiday rates. anaesthetic was recommended by
two pages of news, our regular Chemist Group have confirmed At Chemist Warehouse we 99% of general practitioners who
health & beauty feature plus a they will honour all existing penalty always endeavour to do the right participated in a survey conducted
front cover page from emla. rate payments for current staff thing by our staff as we know earlier this year.
and anyone employed before their commitment, hard work and New pricing on the product is also
Asthma market surge 01 Jul 2017, after the Fair Work dedication is critical, he said. available - see the cover page.
Commissions (FWC) controversial The decision covers all pharmacy
The asthma therapeutics
review of weekend penalty rates. staff across the group including
market in the Asia-Pacific region
Effective next month payments retail assistants, dispensary techs,
is expected to grow from US$4.1
billion last year to about US$6
for Sunday and public holiday work pharmacists, pharmacy students JOIN THE
under the Pharmacy Industry and and any other employees under the
billion by 2023, according to a new
Retail Awards will be reduced under Pharmacy Industry Award 2010 and LEADING
analysis by GBI Research.
The company said the strong
the FWC decision, but Chemist the General Retail Industry Award PROFESSIONAL
Warehouse Group director Damien 2010 who begin work by 01 Jul.
growth would be driven by the
Gance said the company would be Existing penalty rates will be
SERVICES
ageing population in Australia,
India, China, Japan and South Korea
grandfathering existing Sunday honoured for those staff whether PROGRAM IN
as well as increases in pollution, a
or not they are currently rostered
to work on Sundays or holidays.
AUSTRALIA
promising product pipeline and the New cancer approach We value the important
launch of first-in-class molecules the use of resin microspheres contribution made by each staff
- in particular a rise in biologic for the treatment of advanced member, whose engagement and Due to continued
development in the asthma market. Hepatocellular Carcinoma (HCC) or involvement in the business are growth across our
For more see gbiresearch.com. primary liver cancer, the sixth most vital to our success, Gance said. multiple industry
common cancer worldwide, has
leading professional
proven to be superior to current
Sigma, CW in court standard of care therapy, namely Hodgkins drug tick programs, instigo are
A directions hearing in the twice-daily oral doses of sorafenib Opdivo (nivolumab) is now seeking Pharmacists
dispute between Sigma Healthcare (Bayers Nexavar), according to new the first PD-1 inhibitor approved and Account
and Chemist Warehouse is set research data released this week. for a blood cancer, having been Managers to join our
down for this Fri, as the companies The Asia-Pacific Study presented approved by the Australian Professional Services
continue to argue about whether at the 2017 American Society of Therapeutic Goods Administration team in implementing
Chemist Warehouse has the right to Clinical Oncology Meeting revealed (TGA) for use in the treatment coaching and
source generics from an alternative that one-time administration of of adult patients with relapsed mentoring programs.
supplier. microspheres showed a significantly or refractory classical Hodgkin
Sigma confirmed the legal action better tumour response rate of Lymphoma (cHL) under specific
last month (PD 25 May) warning 16.5% than sorafenib with its circumstances.
of a possible annual impact of up 1.7% tumour response rate, and The Bristol-Myers Squibb drug
to $10 million on its bottom line if reportedly less adverse events. is now approved in Australia for
Chemist Warehouse switches. Dubbed SIR-Spheres Y-90 six indications across four distinct
Since the dispute was revealed Resin Microspheres, the product tumour types, including a number
Sigmas shares have plummeted provided a significant increase of solid tumours including non-
almost 30% from $1.19 prior to in the overall Progression-Free small cell lung cancer, melanoma CONTACT
the announcement to trade at 84c Survival rate of 6.3 months. and advanced renal cell cancer. andrew@instigo.com.au
yesterday. Visit sirtex.com for the data. or (02) 9248 2609
Visit tga.gov.au for details.
going
and effectiveness, so
you can enjoy
cold?
a nice hot
Choose the app
cup of coffee
provider that is
promoting your
AND FOCUS ON WHATS IMPORTANT YOUR CUSTOMER
business
CLICK HERE to.meet.the.family
Pharmacy Daily Wednesday 7th June 2017 t 1300 799 220 w www.pharmacydaily.com.au page 1
Wednesday 07 Jun 2017
Atozet/Zeteze relaxed
MSDs Atozet/Zeteze (ezetimibe
Location impacts health Bowel screening
Clinical Genomics is urging
and atorvastatin) has been granted The second Australian Atlas of Elizabeth Koff, Consumers Health Australians aged 50+ to complete a
an extension of its indications to Healthcare Variation, to be formally Forum chair Tony Lawson, former bowel cancer screening test, with
include patients with coronary launched today in Canberra, AMA president Steve Hambleton Jun being Cancer Awareness Month.
heart disease (CHD) and a history of highlights significant variations in and publisher Mia Freedman. Bowel cancer is Australias second
acute coronary syndrome (ACS). the provision of common health The second Atlas focuses largest cancer killer, taking 4,000
The new indication was registered treatments across the country. primarily on hospital care and also lives annually despite being highly
effective 24 May 2017. Developed by the Australian features a greater focus on data treatable if diagnosed early.
Go to tga.gov.au for details. Commission on Safety and Quality specific to Aboriginal and Torres Clinical Genomics developed and
in Health Care, the new edition of Strait Islander health as well as recently launched Colvera in the
the Atlas includes a specific chapter maternal and womens health, the USA, a sensitive and specific blood-
on womens health, with a range social determinants of health and based circulating tumour DNA test
of treatments examined overall on lifestyle diseases. for colorectal cancer recurrence
including hysterectomy, cataract To view the Atlas online see monitoring, which is anticipated to
This week Pharmacy surgery, knee replacements and www.safetyandquality.gov.au. be available in Australia next year.
Daily and Designer diabetes complications.
Brands are giving
away a set each
The document was
developed in collaboration
Champion gets on board
day of their 2017 with federal, state and territory American swimming
Beauty Heaven governments, specialist medical champion and mental health
Glosscar Award colleges, clinicians, consumer advocate Michael Phelps has been
Winners. The representatives and the Australian appointed to the board of Medibio
awards saw DBs Institute of Health and Welfare. Limited, an ASX-listed company
Glow Get Em Almost half of the potentially which has developed an effective,
Bronzer win best preventable hospitalisations in objective test to help with the
new bronzer, while 2014-15 were associated with five diagnosis of depression, chronic
their Pro Brow key conditions: chronic obstructive stress and other mental health
Kit with Stencils pulmonary disease (COPD); disorders.
won best new brow heart failure; complications from Phelps retired from competitive
powder, the Express diabetes; cellulitis; and kidney & swimming last year and since
Makeup Remover urinary tract infections. then has actively sought to raise
won best makeup This indicates a significant awareness of mental health issues.
Remover and the opportunity for the health system Medibios system is based on
Spray and Set Makeup Setting Spray to improve, with access to effective more than 15 years of research Medibio ceo Jack Cosentino
took out the best new tool. CLICK secondary prevention programs at the University of Western welcomed Phelps as a director,
HERE to see more. found to significantly reduce the Australia, and uses patented (and saying the appointment validates
need for hospitalisations. patent pending) circadian, sleep the great need for objective
To win, be the first person from WA mental health diagnosis that we
In fact the new Atlas indicates and autonomic system biomarkers
to send the correct answer to the offer through our industry-leading
there were up to 16-fold variations to objectively quantify and
question to technology.
in the rates of hospital admissions characterise mental illness.
comp@pharmacydaily.com.au Phelps agent Peter Carlisle,
for some chronic conditions. Phelps has used the technology to
How many shades does the DB The report will be launched by analyse his own personal datasets, influential in the Olympic and
Glow Get Em Bronzer come in? Martin Bowles, secretary of the having personally suffered from his sports movement in his own right,
Congratulations to yesterdays winner, Federal Department of Health mental health challenges since he will serve as an alternate board
Carolyn Clifford from Pharmabroker Sales. along with NSW Health secretary was a teenager. member for Medibio Limited.
School of Pharmacy
pharmacy.uq.edu.au
CRICOS Provider No: 00025B | Ethics approval: #2016000996
Pharmacy Daily Wednesday 7th June 2017 t 1300 799 220 w www.pharmacydaily.com.au page 2
f
Dispensary
Health, Beauty
Welcome to our weekly promoted
feature with all the latest health,
Corner beauty and new products for pharmacy.
Pharmacy Daily is Australias favourite pharmacy industry publication. Publisher/Editor in chief: Bruce Piper Editorial: info@pharmacydaily.com.au
Sign up free at www.pharmacydaily.com.au. Managing Editor: Jon Murrie
Postal address: PO Box 1010, Epping, NSW 1710 Australia Reporter: Mal Smith
Street address: Level 2, Suite 1 64 Talavera Rd, Macquarie Park NSW 2113 Australia Contributors: Matt Bell, Jasmine ODonoghue
Advertising and Marketing: Sean Harrigan and Melanie Tchakmadjian advertising@pharmacydaily.com.au
P: 1300 799 220 (+61 2 8007 6760) F: 1300 799 221 (+61 2 8007 6769)
Business Manager: Jenny Piper accounts@pharmacydaily.com.au
Part of the Business Publishing Group.
business events news
Pharmacy Daily is a publication of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission to reproduce any material. While every care has been taken in the preparation of
the newsletter no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial comment is taken by Bruce Piper.
Pharmacy Daily Wednesday 7th June 2017 t 1300 799 220 w www.pharmacydaily.com.au page 3